Abstract PR002: Highly parallel knock-in targeting for genome engineering of cellular therapies
Sign Up to like & getrecommendations! Published in 2021 at "Cancer immunology research"
DOI: 10.1158/2326-6074.tumimm20-pr002
Abstract: Genetically-engineered immune cell therapies have proven effective to treat some types of cancer, but most tumors still cannot be cured. Forward genetics with CRISPR loss-of-function screens in T cells have identified some mutations to enhance… read more here.
Keywords: knock; therapies abstract; immunology; cellular therapies ... See more keywords